A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug.

Dr Benjamin Levy explores research linking alcohol to GI cancers, and how physicians and public health experts can help individuals dramatically reduce their alcohol consumption.